Abstract
Background
Endothelial cell disturbance underpins a role in pathogenesis of atherosclerosis. Notably, accumulating studies indicate the substantial role of microRNAs (miRs) in atherosclerosis, and miR-199a-5p dysregulation has been associated with atherosclerosis and other cardiovascular disorders. However, the effect of miR-199a-5p on the phenotypes of endothelial cells and atherosclerosis remains largely unknown.
Methods
ApoE−/− male mice were fed with high-fat diet for detection of inflammation and aorta plaque area. Extracellular vesicles (EVs) were separated from THP-1-derived macrophage (THP-1-DM) that was treated by oxidized low-density lipoprotein, followed by co-culture with human aortic endothelial cells (HAECs). Ectopic expression and downregulation of miR-199a-5p were done in THP-1-DM-derived EVs to assess pyroptosis and lactate dehydrogenase (LDH) of HAECs. Binding relationship between miR-199a-5p and SMARCA4 was evaluated by luciferase activity assay.
Results
EVs derived from ox-LDL-induced THP-1-DM expedited inflammation and aorta plaque area in atherosclerotic mice. Besides, miR-199a-5p expression was reduced in EVs from ox-LDL-induced THP-1-DM, and miR-199a-5p inhibition facilitated HAEC pyroptosis and LDH activity. Moreover, miR-199a-5p targeted and restricted SMARCA4, and then SMARCA4 activated the NF-κB pathway by increasing PODXL expression in HAECs.
Conclusion
EV-packaged inhibited miR-199a-5p from macrophages expedites endothelial cell pyroptosis and further accelerates atherosclerosis through the SMARCA4/PODXL/NF-κB axis, providing promising targets and strategies for the prevention and treatment of atherosclerosis.
Graphical abstract
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are available in the manuscript and supplementary materials.
Code availability
Not applicable.
Abbreviations
- miRs:
-
MicroRNAs
- EVs:
-
Extracellular vesicles
- THP-1-DM:
-
THP-1-derived macrophage
- HAECs:
-
Human aortic endothelial cells
- LDH:
-
Lactate dehydrogenase
- EVs:
-
Extracellular vesicles
- SMARCA4:
-
SWI/SNF-related, matrix associated, actin-dependent regulator of chromatin, subfamily a, member 4
- PODXL:
-
Podocalyxin like
- qRT-PCR:
-
Quantitative reverse transcription polymerase chain reaction
- un-EVs:
-
EVs from DMSO-treated THP-1-DMs
- FBS:
-
Fetal bovine serum
- PMA:
-
Phorbol-12-myristate-13-acetate
- ox-LDL:
-
Oxidized low-density lipoprotein
- PBS:
-
Phosphate-buffered saline
- NC:
-
Negative control
- GFP:
-
Green fluorescent protein
- TEM:
-
Transmission electron microscope
- DAPI:
-
4′,6-Diamidino-2-phenylindole
- LDH:
-
Lactate dehydrogenase
- ELISA:
-
Enzyme-linked immunosorbent assay
References
Borg D, Hedner C, Nodin B, Larsson A, Johnsson A, Eberhard J, et al. Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma. BMC Clin Pathol. 2016;16:13.
Chen SJ, Tsui PF, Chuang YP, Chiang DM, Chen LW, Liu ST, et al. Carvedilol ameliorates experimental atherosclerosis by regulating cholesterol efflux and exosome functions. Int J Mol Sci. 2019;20(20):5202. doi: 10.3390/ijms20205202.
Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen MJ, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation. 2006;113(23):2744–53.
Cui A, Hu Z, Han Y, Yang Y, Li Y. Optimized analysis of in vivo and in vitro hepatic steatosis. J Vis Exp. 2017;(121):55178. doi: 10.3791/55178.
de Winther MP, Kanters E, Kraal G, Hofker MH. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol. 2005;25(5):904–14.
Fang F, Chen D, Yu L, Dai X, Yang Y, Tian W, et al. Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. Circ Res. 2013;113(8):986–96.
Fang T, Lv H, Lv G, Li T, Wang C, Han Q, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9(1):191.
Feinberg MW, Moore KJ. MicroRNA regulation of atherosclerosis. Circ Res. 2016;118(4):703–20.
Griffin CT, Curtis CD, Davis RB, Muthukumar V, Magnuson T. The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels. Proc Natl Acad Sci U S A. 2011;108(6):2282–7.
He X, Zheng Y, Liu S, Shi S, Liu Y, He Y, et al. MiR-146a protects small intestine against ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-kappaB pathway. J Cell Physiol. 2018;233(3):2476–88.
Hornick NI, Doron B, Abdelhamed S, Huan J, Harrington CA, Shen R, et al. AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB. Sci Signal. 2016;9(444):ra88.
Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H. NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol. 2018;233(3):2116–32.
Laffont B, Rayner KJ. MicroRNAs in the pathobiology and therapy of atherosclerosis. Can J Cardiol. 2017;33(3):313–24.
Lee SJ, Jung YH, Song EJ, Jang KK, Choi SH, Han HJ. Vibrio vulnificus VvpE Stimulates IL-1beta production by the hypomethylation of the IL-1beta promoter and NF-kappaB activation via lipid raft-dependent ANXA2 recruitment and reactive oxygen species signaling in intestinal epithelial cells. J Immunol. 2015;195(5):2282–93.
Li X, Yao N, Zhang J, Liu Z. MicroRNA-125b is involved in atherosclerosis obliterans in vitro by targeting podocalyxin. Mol Med Rep. 2015;12(1):561–8.
Li Z, Zhang Y, Zhang Y, Yu L, Xiao B, Li T, et al. BRG1 stimulates endothelial derived alarmin MRP8 to promote macrophage infiltration in an animal model of cardiac hypertrophy. Front Cell Dev Biol. 2020;8:569.
Luo K. Signaling Cross Talk between TGF-beta/Smad and other signaling pathways. Cold Spring Harb Perspect Biol. 2017;9(1):a022137.
M’Baya-Moutoula E, Louvet L, Molinie R, Guerrera IC, Cerutti C, Fourdinier O, et al. A multi-omics analysis of the regulatory changes induced by miR-223 in a monocyte/macrophage cell line. Biochim Biophys Acta Mol Basis Dis. 2018;1864(8):2664–78.
McDonald MK, Tian Y, Qureshi RA, Gormley M, Ertel A, Gao R, et al. Functional significance of macrophage-derived exosomes in inflammation and pain. Pain. 2014;155(8):1527–39.
Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013;13(10):709–21.
Nguyen MA, Karunakaran D, Geoffrion M, Cheng HS, Tandoc K, PerisicMatic L, et al. Extracellular vesicles secreted by atherogenic macrophages transfer microRNA to inhibit cell migration. Arterioscler Thromb Vasc Biol. 2018;38(1):49–63.
Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007;8(1):49–62.
Qiao XR, Wang L, Liu M, Tian Y, Chen T. MiR-210-3p attenuates lipid accumulation and inflammation in atherosclerosis by repressing IGF2. Biosci Biotechnol Biochem. 2020;84(2):321–9.
Sassetti C, Tangemann K, Singer MS, Kershaw DB, Rosen SD. Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34. J Exp Med. 1998;187(12):1965–75.
Sizemore S, Cicek M, Sizemore N, Ng KP, Casey G. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res. 2007;67(13):6183–91.
Stankovic A, Kolakovic A, Zivkovic M, Djuric T, Bundalo M, Koncar I, et al. Angiotensin receptor type 1 polymorphism A1166C is associated with altered AT1R and miR-155 expression in carotid plaque tissue and development of hypoechoic carotid plaques. Atherosclerosis. 2016;248:132–9.
Sun Y, Zhao JT, Chi BJ, Wang KF. Long noncoding RNA SNHG12 promotes vascular smooth muscle cell proliferation and migration via regulating miR-199a-5p/HIF-1alpha. Cell Biol Int. 2020;44(8):1714–26.
Tian X, Yu C, Shi L, Li D, Chen X, Xia D, et al. MicroRNA-199a-5p aggravates primary hypertension by damaging vascular endothelial cells through inhibition of autophagy and promotion of apoptosis. Exp Ther Med. 2018;16(2):595–602.
Wang J, Wang WN, Xu SB, Wu H, Dai B, Jian DD, et al. MicroRNA-214–3p: a link between autophagy and endothelial cell dysfunction in atherosclerosis. Acta Physiol (Oxf). 2018;222(3). https://doi.org/10.1111/apha.12973.
Wang JM, Chen AF, Zhang K. Isolation and primary culture of mouse aortic endothelial cells. J Vis Exp. 2016;(118):52965.https://doi.org/10.3791/52965.
Wu H, Yang L, Liao D, Chen Y, Wang W, Fang J. Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide. Exp Ther Med. 2013;5(4):1025–9.
Wu X, Zhang H, Qi W, Zhang Y, Li J, Li Z, et al. Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death Dis. 2018;9(2):171.
Xu Y, Fang F. Regulatory role of Brg1 and Brm in the vasculature: from organogenesis to stress-induced cardiovascular disease. Cardiovasc Hematol Disord Drug Targets. 2012;12(2):141–5.
Xu YJ, Zheng L, Hu YW, Wang Q. Pyroptosis and its relationship to atherosclerosis. Clin Chim Acta. 2018;476:28–37.
Zhang J, Wang Z, Zhang J, Zuo G, Li B, Mao W, et al. Rapamycin attenuates endothelial apoptosis induced by low shear stress via mTOR and sestrin1 related redox regulation. Mediators Inflamm. 2014;2014: 769608.
Zhang X, Liu S, Weng X, Zeng S, Yu L, Guo J, et al. Brg1 deficiency in vascular endothelial cells blocks neutrophil recruitment and ameliorates cardiac ischemia-reperfusion injury in mice. Int J Cardiol. 2018;269:250–8.
Zhaolin Z, Jiaojiao C, Peng W, Yami L, Tingting Z, Jun T, et al. OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p/TET2 pathway. J Cell Physiol. 2019;234(5):7475–91.
Zhi Q, Chen H, Liu F, Han Y, Wan D, Xu Z, et al. Podocalyxin-like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 protein. Cancer Sci. 2019;110(1):118–34.
Zhu J, Liu B, Wang Z, Wang D, Ni H, Zhang L, et al. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation. Theranostics. 2019;9(23):6901–19.
Funding
This work was funded by Guangzhou City Health and Family Planning Science and Technology Project (No.20181A011114).
Author information
Authors and Affiliations
Contributions
Weijie Liang, Jun Chen, and Hongyan Zheng wrote the paper; Aiwen Lin, Jianhao Li, and Wen Wu conceived the experiments; Qiang Jie and Weijie Liang analyzed the data; Jun Chen and Hongyan Zheng collected and provided the sample for this study. All the authors have read and approved the final submitted manuscript.
Corresponding authors
Ethics declarations
Ethics approval
The experiments involved animals were implemented under approval of the animal ethics committee of Guangdong Provincial People's Hospital (Approval number: NO.GDREC2019275A).
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Graphical Headlights
1. ox-LDL downregulates miR-199a-5p expression in macrophage-derived EVs.
2. EVs-miR-199a-5p inhibits endothelial pyroptosis.
3. EVs-miR-199a-5p targets SMARCA4 and inhibits PODXL/NF-κB axis to reduce endothelial pyroptosis.
4. EVs-miR-199a-5p inhibits endothelial pyroptosis and ultimately alleviates atherogenesis.
Supplementary Information
Below is the link to the electronic supplementary material.
10565_2022_9732_MOESM1_ESM.jpg
Supplementary file1 (JPG 333 kb) SUPPLEMENTARY FIGURE 1 Morphology of isolated mouse aortic ECs in microscopic observation.
10565_2022_9732_MOESM2_ESM.jpg
Supplementary file2 (JPG 1355 kb) SUPPLEMENTARY FIGURE 2 ox-LDL-hMDM-EVs and hMDM-EVs-miR-199a-5p participate in the atherosclerosis of ApoE-/- mice. A, The lesion area on the frontal plaque of mouse aorta in response to EVs derived from hMDMs treated with/without ox-LDL (un-EVs and ox-LDL-EVs), as detected by oil red O staining. B, The lesion area of mice aortic root plaque in response to un-EVs or ox-LDL-EVs, as detected by oil red O staining. C, ELISA assay showing the content of inflammation-related factors in mice serum in response to un-EVs or ox-LDL-EVs. D, The expression level of miR-199a-5p in hMDMs treated with/without ox-LDL, as determined with qRT-PCR. E, The expression level of miR-199a-5p in un-EVs or ox-LDL-EVs, as determined with qRT-PCR. F, qRT-PCR detection of the efficiency of lentivirus-mediated transduction of miR-199a-5p mimic/inhibitor. G, The expression level of miR-199a-5p in EVs derived from miR-199a-5p-overexpressing/inhibiting cells (EV-miR-199a-5p/EV-miR-199a-5p-inhibitor). H, The lesion area on the frontal plaque of mouse aorta in response to EV-miR-199a-5p/EV-miR-199a-5p-inhibitor, as detected by oil red O staining. I, The lesion area of mice aortic root plaque in response to EV-miR-199a-5p/EV-miR-199a-5p-inhibitor, as detected by oil red O staining. J, ELISA assay showing the content of inflammation-related factors in mice serum in response to EV-miR-199a-5p/EV-miR-199a-5p-inhibitor. n = 10. *p < 0.05, **p < 0.01, ***p < 0.001. Cell experiments were repeated 3 times.
10565_2022_9732_MOESM3_ESM.jpg
Supplementary file3 (JPG 291 kb) SUPPLEMENTARY FIGURE 3 Detection of serum lipids following treatment with THP-1-DMs and hMDMs and corresponding EVs. A, The level of ox-LDL in HP-1-DMs and hMDMs treated with/without ox-LDL and in corresponding EVs, as determined with an ox-LDL detection kit. B, Serum levels of TC, TG, LDL-C and HDL-C in mice treated with un-EVs/ox-LDL-EVs. n = 10. *p < 0.05, **p < 0.01, ***p < 0.001. Cell experiments were repeated 3 times.
10565_2022_9732_MOESM4_ESM.jpg
Supplementary file4 (JPG 368 kb) SUPPLEMENTARY FIGURE 4 miR-199a-3p expression following miR-199a-5p mimic/inhibitor and miR-199a-5p/miR-199a-3p sequence. A, The expression of miR-199a-3p in HAECs treated with miR-199a-5p mimic/inhibitor. B, Sequences of miR-199a-5p and miR-199a-3p. *p < 0.05. Cell experiments were repeated 3 times.
10565_2022_9732_MOESM5_ESM.jpg
Supplementary file5 (JPG 584 kb) SUPPLEMENTARY FIGURE 5 The expression of miR-199a-5p in atherosclerotic mice and HAECs and the EV internalization over LSS exposure time. A, The expression of miR-199a-5p in atherosclerotic mice and control mice. B, The expression of miR-199a-5p in HAECs in response to LSS treatment for 0, 30, 60 and 120 min. C, Laser scanning confocal microscopy to detect EV internalization by HAECs under exposure to LSS, as reflected by the fluorescence intensity of PKH26 (red), with DAPI-labeled nuclei in blue. n = 10. *p < 0.05, **p < 0.01.
Rights and permissions
About this article
Cite this article
Liang, W., Chen, J., Zheng, H. et al. MiR-199a-5p-containing macrophage-derived extracellular vesicles inhibit SMARCA4 and alleviate atherosclerosis by reducing endothelial cell pyroptosis. Cell Biol Toxicol 39, 591–605 (2023). https://doi.org/10.1007/s10565-022-09732-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10565-022-09732-2